Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Surgery and discontinuation of angiotensin converting enzyme inhibitors: current perspectives (CROSBI ID 298774)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Bradic, Nikola ; Povsic-Cevra, Zdenko Surgery and discontinuation of angiotensin converting enzyme inhibitors: current perspectives // Current Opinion in Anesthesiology, 31 (2018), 1; 50-54

Podaci o odgovornosti

Bradic, Nikola ; Povsic-Cevra, Zdenko

engleski

Surgery and discontinuation of angiotensin converting enzyme inhibitors: current perspectives

Since the introduction of ACEIs and ARBs into clinical practice, their use during the perioperative period has been controversial. Although these medications increase the risk of serious hypotension immediately after induction and maintenance of anesthesia, their use has numerous benefits, making it reasonable to continue them during perioperative period.

ACEI ; ARB ; perioperative

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

31 (1)

2018.

50-54

objavljeno

0952-7907

1473-6500

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost